Skip to main content

Table 2 Comparison of selected PK parameters among VEGF inhibitors

From: A novel engineered VEGF blocker with an excellent pharmacokinetic profile and robust anti-tumor activity

Inhibitor pI Dose (mg/kg) Cmax(μg/ml) AUC (μg · days/ml) Reference
HB-002.1 6.7 2.5 20.3 81.46 This study
Bevacizumab 7.6 9.3 74.1 682 39
Parental VEGF-Trap 9.4 4.0 0.05 0.04 24
VEGF-TRAP∆B1 9.1 4.0 1.3 1.36 24
VEGF-TRAP∆B2 8.9 4.0 2.65 5.42 24
Aflibercept 8.82 4.0 16 36.28 24
\